News
The latest science and news from the Institute.
-
Identifying tumour characteristics to predict immunotherapy response
6th September 2023
Tumour characteristics could be used to predict whether patients with an aggressive subtype of breast cancer are able to respond to immunotherapy.
Find out more -
Minderoo Precision Brain Tumour Programme tops recruitment milestones
9th May 2023
The Minderoo Precision Brain Tumour Programme is providing patients in the UK with access to a new level of innovation and excellence in treatment and
Find out more -
Cambridge pilots landmark NHS testing and treatment for brain cancer
16th April 2022
Brain tumour patients at Addenbrooke’s Hospital are the first in the UK to benefit from personalised treatment using the latest advances in genomics and targeted therapies.
Find out more -
Personalised blood test can detect persistent lung cancer
17th March 2022
Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to researchers at the University of Cambridge.
-
Largest genetic database of Asian breast cancers
4th January 2021
Researchers from the Caldas Group have collaborated with the Subang Jaya Medical Centre and Cancer Research Malaysia to build the largest genetic and genomic database of Asian breast cancers.
Find out more -
New blood test to monitor cancer up to ten times more sensitive than current methods
17th June 2020
A new method of analysing cancer patients’ blood for evidence of the disease could be up to ten times more sensitive than previous methods.
Find out more -
Highly sensitive blood test could improve breast cancer treatment
7th August 2019
A new, highly sensitive blood test is one of the first to successfully monitor breast cancer patients with early stage disease.
Find out more -
Identifying active targets in hard to treat cancers
30th April 2019
Dr Geoff Macintyre and Dr Anna Piskorz have received a Cancer Research UK Innovation Prize to develop a test that could identify active therapeutic targets in hard to treat cancers.
Find out more -
Molecular patterns could better predict breast cancer recurrence
13th March 2019
The genetic and molecular make-up of individual breast tumours holds clues to how a woman’s disease could progress, including the likelihood of it coming back after treatment, and in what time frame.
Find out more